Global Favipiravir Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Favipiravir Tablets market size was valued at USD 2193.7 million in 2023 and is forecast to a readjusted size of USD 2958.2 million by 2030 with a CAGR of 4.4% during review period.

Favipiravir is an antiviral drug which has been licenced in Japan since 2014 to treat influenza. It works by inhibiting a viral enzyme called RNA polymerase, preventing viral replication within human cells. This viral enzyme is common to several viruses, including SARS-CoV-2, which causes COVID-19. The drug has shown positive results against SARS-CoV-2 in laboratory and animal studies, with small pilot studies in humans demonstrating some benefit in reducing symptoms and the duration of illness.

The Global Info Research report includes an overview of the development of the Favipiravir Tablets industry chain, the market status of Influenza Viruses (Brand Drug, Generic Drug), COVID-19 (Brand Drug, Generic Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Favipiravir Tablets.

Regionally, the report analyzes the Favipiravir Tablets markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Favipiravir Tablets market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Favipiravir Tablets market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Favipiravir Tablets industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Brand Drug, Generic Drug).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Favipiravir Tablets market.

Regional Analysis: The report involves examining the Favipiravir Tablets market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Favipiravir Tablets market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Favipiravir Tablets:
Company Analysis: Report covers individual Favipiravir Tablets manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Favipiravir Tablets This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Influenza Viruses, COVID-19).

Technology Analysis: Report covers specific technologies relevant to Favipiravir Tablets. It assesses the current state, advancements, and potential future developments in Favipiravir Tablets areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Favipiravir Tablets market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Favipiravir Tablets market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Brand Drug
    Generic Drug

Market segment by Application
    Influenza Viruses
    COVID-19
    Others

Major players covered
    ChemRar Group
    Glenmark
    Fujifilm
    Dr. Reddy
    R-Pharma
    Cipla
    Lupin
    Sun Pharma
    Hisun Pharm

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Favipiravir Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Favipiravir Tablets, with price, sales, revenue and global market share of Favipiravir Tablets from 2019 to 2024.
Chapter 3, the Favipiravir Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Favipiravir Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Favipiravir Tablets market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Favipiravir Tablets.
Chapter 14 and 15, to describe Favipiravir Tablets sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Favipiravir Tablets
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Favipiravir Tablets Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Brand Drug
        1.3.3 Generic Drug
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Favipiravir Tablets Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Influenza Viruses
        1.4.3 COVID-19
        1.4.4 Others
    1.5 Global Favipiravir Tablets Market Size & Forecast
        1.5.1 Global Favipiravir Tablets Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Favipiravir Tablets Sales Quantity (2019-2030)
        1.5.3 Global Favipiravir Tablets Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 ChemRar Group
        2.1.1 ChemRar Group Details
        2.1.2 ChemRar Group Major Business
        2.1.3 ChemRar Group Favipiravir Tablets Product and Services
        2.1.4 ChemRar Group Favipiravir Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 ChemRar Group Recent Developments/Updates
    2.2 Glenmark
        2.2.1 Glenmark Details
        2.2.2 Glenmark Major Business
        2.2.3 Glenmark Favipiravir Tablets Product and Services
        2.2.4 Glenmark Favipiravir Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Glenmark Recent Developments/Updates
    2.3 Fujifilm
        2.3.1 Fujifilm Details
        2.3.2 Fujifilm Major Business
        2.3.3 Fujifilm Favipiravir Tablets Product and Services
        2.3.4 Fujifilm Favipiravir Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Fujifilm Recent Developments/Updates
    2.4 Dr. Reddy
        2.4.1 Dr. Reddy Details
        2.4.2 Dr. Reddy Major Business
        2.4.3 Dr. Reddy Favipiravir Tablets Product and Services
        2.4.4 Dr. Reddy Favipiravir Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Dr. Reddy Recent Developments/Updates
    2.5 R-Pharma
        2.5.1 R-Pharma Details
        2.5.2 R-Pharma Major Business
        2.5.3 R-Pharma Favipiravir Tablets Product and Services
        2.5.4 R-Pharma Favipiravir Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 R-Pharma Recent Developments/Updates
    2.6 Cipla
        2.6.1 Cipla Details
        2.6.2 Cipla Major Business
        2.6.3 Cipla Favipiravir Tablets Product and Services
        2.6.4 Cipla Favipiravir Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Cipla Recent Developments/Updates
    2.7 Lupin
        2.7.1 Lupin Details
        2.7.2 Lupin Major Business
        2.7.3 Lupin Favipiravir Tablets Product and Services
        2.7.4 Lupin Favipiravir Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Lupin Recent Developments/Updates
    2.8 Sun Pharma
        2.8.1 Sun Pharma Details
        2.8.2 Sun Pharma Major Business
        2.8.3 Sun Pharma Favipiravir Tablets Product and Services
        2.8.4 Sun Pharma Favipiravir Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Sun Pharma Recent Developments/Updates
    2.9 Hisun Pharm
        2.9.1 Hisun Pharm Details
        2.9.2 Hisun Pharm Major Business
        2.9.3 Hisun Pharm Favipiravir Tablets Product and Services
        2.9.4 Hisun Pharm Favipiravir Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Hisun Pharm Recent Developments/Updates

3 Competitive Environment: Favipiravir Tablets by Manufacturer
    3.1 Global Favipiravir Tablets Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Favipiravir Tablets Revenue by Manufacturer (2019-2024)
    3.3 Global Favipiravir Tablets Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Favipiravir Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Favipiravir Tablets Manufacturer Market Share in 2023
        3.4.2 Top 6 Favipiravir Tablets Manufacturer Market Share in 2023
    3.5 Favipiravir Tablets Market: Overall Company Footprint Analysis
        3.5.1 Favipiravir Tablets Market: Region Footprint
        3.5.2 Favipiravir Tablets Market: Company Product Type Footprint
        3.5.3 Favipiravir Tablets Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Favipiravir Tablets Market Size by Region
        4.1.1 Global Favipiravir Tablets Sales Quantity by Region (2019-2030)
        4.1.2 Global Favipiravir Tablets Consumption Value by Region (2019-2030)
        4.1.3 Global Favipiravir Tablets Average Price by Region (2019-2030)
    4.2 North America Favipiravir Tablets Consumption Value (2019-2030)
    4.3 Europe Favipiravir Tablets Consumption Value (2019-2030)
    4.4 Asia-Pacific Favipiravir Tablets Consumption Value (2019-2030)
    4.5 South America Favipiravir Tablets Consumption Value (2019-2030)
    4.6 Middle East and Africa Favipiravir Tablets Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Favipiravir Tablets Sales Quantity by Type (2019-2030)
    5.2 Global Favipiravir Tablets Consumption Value by Type (2019-2030)
    5.3 Global Favipiravir Tablets Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Favipiravir Tablets Sales Quantity by Application (2019-2030)
    6.2 Global Favipiravir Tablets Consumption Value by Application (2019-2030)
    6.3 Global Favipiravir Tablets Average Price by Application (2019-2030)

7 North America
    7.1 North America Favipiravir Tablets Sales Quantity by Type (2019-2030)
    7.2 North America Favipiravir Tablets Sales Quantity by Application (2019-2030)
    7.3 North America Favipiravir Tablets Market Size by Country
        7.3.1 North America Favipiravir Tablets Sales Quantity by Country (2019-2030)
        7.3.2 North America Favipiravir Tablets Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Favipiravir Tablets Sales Quantity by Type (2019-2030)
    8.2 Europe Favipiravir Tablets Sales Quantity by Application (2019-2030)
    8.3 Europe Favipiravir Tablets Market Size by Country
        8.3.1 Europe Favipiravir Tablets Sales Quantity by Country (2019-2030)
        8.3.2 Europe Favipiravir Tablets Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Favipiravir Tablets Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Favipiravir Tablets Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Favipiravir Tablets Market Size by Region
        9.3.1 Asia-Pacific Favipiravir Tablets Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Favipiravir Tablets Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Favipiravir Tablets Sales Quantity by Type (2019-2030)
    10.2 South America Favipiravir Tablets Sales Quantity by Application (2019-2030)
    10.3 South America Favipiravir Tablets Market Size by Country
        10.3.1 South America Favipiravir Tablets Sales Quantity by Country (2019-2030)
        10.3.2 South America Favipiravir Tablets Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Favipiravir Tablets Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Favipiravir Tablets Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Favipiravir Tablets Market Size by Country
        11.3.1 Middle East & Africa Favipiravir Tablets Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Favipiravir Tablets Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Favipiravir Tablets Market Drivers
    12.2 Favipiravir Tablets Market Restraints
    12.3 Favipiravir Tablets Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Favipiravir Tablets and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Favipiravir Tablets
    13.3 Favipiravir Tablets Production Process
    13.4 Favipiravir Tablets Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Favipiravir Tablets Typical Distributors
    14.3 Favipiravir Tablets Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Favipiravir Tablets Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Favipiravir Tablets Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. ChemRar Group Basic Information, Manufacturing Base and Competitors
    Table 4. ChemRar Group Major Business
    Table 5. ChemRar Group Favipiravir Tablets Product and Services
    Table 6. ChemRar Group Favipiravir Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. ChemRar Group Recent Developments/Updates
    Table 8. Glenmark Basic Information, Manufacturing Base and Competitors
    Table 9. Glenmark Major Business
    Table 10. Glenmark Favipiravir Tablets Product and Services
    Table 11. Glenmark Favipiravir Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Glenmark Recent Developments/Updates
    Table 13. Fujifilm Basic Information, Manufacturing Base and Competitors
    Table 14. Fujifilm Major Business
    Table 15. Fujifilm Favipiravir Tablets Product and Services
    Table 16. Fujifilm Favipiravir Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Fujifilm Recent Developments/Updates
    Table 18. Dr. Reddy Basic Information, Manufacturing Base and Competitors
    Table 19. Dr. Reddy Major Business
    Table 20. Dr. Reddy Favipiravir Tablets Product and Services
    Table 21. Dr. Reddy Favipiravir Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Dr. Reddy Recent Developments/Updates
    Table 23. R-Pharma Basic Information, Manufacturing Base and Competitors
    Table 24. R-Pharma Major Business
    Table 25. R-Pharma Favipiravir Tablets Product and Services
    Table 26. R-Pharma Favipiravir Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. R-Pharma Recent Developments/Updates
    Table 28. Cipla Basic Information, Manufacturing Base and Competitors
    Table 29. Cipla Major Business
    Table 30. Cipla Favipiravir Tablets Product and Services
    Table 31. Cipla Favipiravir Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Cipla Recent Developments/Updates
    Table 33. Lupin Basic Information, Manufacturing Base and Competitors
    Table 34. Lupin Major Business
    Table 35. Lupin Favipiravir Tablets Product and Services
    Table 36. Lupin Favipiravir Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Lupin Recent Developments/Updates
    Table 38. Sun Pharma Basic Information, Manufacturing Base and Competitors
    Table 39. Sun Pharma Major Business
    Table 40. Sun Pharma Favipiravir Tablets Product and Services
    Table 41. Sun Pharma Favipiravir Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Sun Pharma Recent Developments/Updates
    Table 43. Hisun Pharm Basic Information, Manufacturing Base and Competitors
    Table 44. Hisun Pharm Major Business
    Table 45. Hisun Pharm Favipiravir Tablets Product and Services
    Table 46. Hisun Pharm Favipiravir Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Hisun Pharm Recent Developments/Updates
    Table 48. Global Favipiravir Tablets Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 49. Global Favipiravir Tablets Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 50. Global Favipiravir Tablets Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 51. Market Position of Manufacturers in Favipiravir Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 52. Head Office and Favipiravir Tablets Production Site of Key Manufacturer
    Table 53. Favipiravir Tablets Market: Company Product Type Footprint
    Table 54. Favipiravir Tablets Market: Company Product Application Footprint
    Table 55. Favipiravir Tablets New Market Entrants and Barriers to Market Entry
    Table 56. Favipiravir Tablets Mergers, Acquisition, Agreements, and Collaborations
    Table 57. Global Favipiravir Tablets Sales Quantity by Region (2019-2024) & (K Units)
    Table 58. Global Favipiravir Tablets Sales Quantity by Region (2025-2030) & (K Units)
    Table 59. Global Favipiravir Tablets Consumption Value by Region (2019-2024) & (USD Million)
    Table 60. Global Favipiravir Tablets Consumption Value by Region (2025-2030) & (USD Million)
    Table 61. Global Favipiravir Tablets Average Price by Region (2019-2024) & (US$/Unit)
    Table 62. Global Favipiravir Tablets Average Price by Region (2025-2030) & (US$/Unit)
    Table 63. Global Favipiravir Tablets Sales Quantity by Type (2019-2024) & (K Units)
    Table 64. Global Favipiravir Tablets Sales Quantity by Type (2025-2030) & (K Units)
    Table 65. Global Favipiravir Tablets Consumption Value by Type (2019-2024) & (USD Million)
    Table 66. Global Favipiravir Tablets Consumption Value by Type (2025-2030) & (USD Million)
    Table 67. Global Favipiravir Tablets Average Price by Type (2019-2024) & (US$/Unit)
    Table 68. Global Favipiravir Tablets Average Price by Type (2025-2030) & (US$/Unit)
    Table 69. Global Favipiravir Tablets Sales Quantity by Application (2019-2024) & (K Units)
    Table 70. Global Favipiravir Tablets Sales Quantity by Application (2025-2030) & (K Units)
    Table 71. Global Favipiravir Tablets Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. Global Favipiravir Tablets Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. Global Favipiravir Tablets Average Price by Application (2019-2024) & (US$/Unit)
    Table 74. Global Favipiravir Tablets Average Price by Application (2025-2030) & (US$/Unit)
    Table 75. North America Favipiravir Tablets Sales Quantity by Type (2019-2024) & (K Units)
    Table 76. North America Favipiravir Tablets Sales Quantity by Type (2025-2030) & (K Units)
    Table 77. North America Favipiravir Tablets Sales Quantity by Application (2019-2024) & (K Units)
    Table 78. North America Favipiravir Tablets Sales Quantity by Application (2025-2030) & (K Units)
    Table 79. North America Favipiravir Tablets Sales Quantity by Country (2019-2024) & (K Units)
    Table 80. North America Favipiravir Tablets Sales Quantity by Country (2025-2030) & (K Units)
    Table 81. North America Favipiravir Tablets Consumption Value by Country (2019-2024) & (USD Million)
    Table 82. North America Favipiravir Tablets Consumption Value by Country (2025-2030) & (USD Million)
    Table 83. Europe Favipiravir Tablets Sales Quantity by Type (2019-2024) & (K Units)
    Table 84. Europe Favipiravir Tablets Sales Quantity by Type (2025-2030) & (K Units)
    Table 85. Europe Favipiravir Tablets Sales Quantity by Application (2019-2024) & (K Units)
    Table 86. Europe Favipiravir Tablets Sales Quantity by Application (2025-2030) & (K Units)
    Table 87. Europe Favipiravir Tablets Sales Quantity by Country (2019-2024) & (K Units)
    Table 88. Europe Favipiravir Tablets Sales Quantity by Country (2025-2030) & (K Units)
    Table 89. Europe Favipiravir Tablets Consumption Value by Country (2019-2024) & (USD Million)
    Table 90. Europe Favipiravir Tablets Consumption Value by Country (2025-2030) & (USD Million)
    Table 91. Asia-Pacific Favipiravir Tablets Sales Quantity by Type (2019-2024) & (K Units)
    Table 92. Asia-Pacific Favipiravir Tablets Sales Quantity by Type (2025-2030) & (K Units)
    Table 93. Asia-Pacific Favipiravir Tablets Sales Quantity by Application (2019-2024) & (K Units)
    Table 94. Asia-Pacific Favipiravir Tablets Sales Quantity by Application (2025-2030) & (K Units)
    Table 95. Asia-Pacific Favipiravir Tablets Sales Quantity by Region (2019-2024) & (K Units)
    Table 96. Asia-Pacific Favipiravir Tablets Sales Quantity by Region (2025-2030) & (K Units)
    Table 97. Asia-Pacific Favipiravir Tablets Consumption Value by Region (2019-2024) & (USD Million)
    Table 98. Asia-Pacific Favipiravir Tablets Consumption Value by Region (2025-2030) & (USD Million)
    Table 99. South America Favipiravir Tablets Sales Quantity by Type (2019-2024) & (K Units)
    Table 100. South America Favipiravir Tablets Sales Quantity by Type (2025-2030) & (K Units)
    Table 101. South America Favipiravir Tablets Sales Quantity by Application (2019-2024) & (K Units)
    Table 102. South America Favipiravir Tablets Sales Quantity by Application (2025-2030) & (K Units)
    Table 103. South America Favipiravir Tablets Sales Quantity by Country (2019-2024) & (K Units)
    Table 104. South America Favipiravir Tablets Sales Quantity by Country (2025-2030) & (K Units)
    Table 105. South America Favipiravir Tablets Consumption Value by Country (2019-2024) & (USD Million)
    Table 106. South America Favipiravir Tablets Consumption Value by Country (2025-2030) & (USD Million)
    Table 107. Middle East & Africa Favipiravir Tablets Sales Quantity by Type (2019-2024) & (K Units)
    Table 108. Middle East & Africa Favipiravir Tablets Sales Quantity by Type (2025-2030) & (K Units)
    Table 109. Middle East & Africa Favipiravir Tablets Sales Quantity by Application (2019-2024) & (K Units)
    Table 110. Middle East & Africa Favipiravir Tablets Sales Quantity by Application (2025-2030) & (K Units)
    Table 111. Middle East & Africa Favipiravir Tablets Sales Quantity by Region (2019-2024) & (K Units)
    Table 112. Middle East & Africa Favipiravir Tablets Sales Quantity by Region (2025-2030) & (K Units)
    Table 113. Middle East & Africa Favipiravir Tablets Consumption Value by Region (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Favipiravir Tablets Consumption Value by Region (2025-2030) & (USD Million)
    Table 115. Favipiravir Tablets Raw Material
    Table 116. Key Manufacturers of Favipiravir Tablets Raw Materials
    Table 117. Favipiravir Tablets Typical Distributors
    Table 118. Favipiravir Tablets Typical Customers
List of Figures
    Figure 1. Favipiravir Tablets Picture
    Figure 2. Global Favipiravir Tablets Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Favipiravir Tablets Consumption Value Market Share by Type in 2023
    Figure 4. Brand Drug Examples
    Figure 5. Generic Drug Examples
    Figure 6. Global Favipiravir Tablets Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Favipiravir Tablets Consumption Value Market Share by Application in 2023
    Figure 8. Influenza Viruses Examples
    Figure 9. COVID-19 Examples
    Figure 10. Others Examples
    Figure 11. Global Favipiravir Tablets Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Favipiravir Tablets Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Favipiravir Tablets Sales Quantity (2019-2030) & (K Units)
    Figure 14. Global Favipiravir Tablets Average Price (2019-2030) & (US$/Unit)
    Figure 15. Global Favipiravir Tablets Sales Quantity Market Share by Manufacturer in 2023
    Figure 16. Global Favipiravir Tablets Consumption Value Market Share by Manufacturer in 2023
    Figure 17. Producer Shipments of Favipiravir Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 18. Top 3 Favipiravir Tablets Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Top 6 Favipiravir Tablets Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Global Favipiravir Tablets Sales Quantity Market Share by Region (2019-2030)
    Figure 21. Global Favipiravir Tablets Consumption Value Market Share by Region (2019-2030)
    Figure 22. North America Favipiravir Tablets Consumption Value (2019-2030) & (USD Million)
    Figure 23. Europe Favipiravir Tablets Consumption Value (2019-2030) & (USD Million)
    Figure 24. Asia-Pacific Favipiravir Tablets Consumption Value (2019-2030) & (USD Million)
    Figure 25. South America Favipiravir Tablets Consumption Value (2019-2030) & (USD Million)
    Figure 26. Middle East & Africa Favipiravir Tablets Consumption Value (2019-2030) & (USD Million)
    Figure 27. Global Favipiravir Tablets Sales Quantity Market Share by Type (2019-2030)
    Figure 28. Global Favipiravir Tablets Consumption Value Market Share by Type (2019-2030)
    Figure 29. Global Favipiravir Tablets Average Price by Type (2019-2030) & (US$/Unit)
    Figure 30. Global Favipiravir Tablets Sales Quantity Market Share by Application (2019-2030)
    Figure 31. Global Favipiravir Tablets Consumption Value Market Share by Application (2019-2030)
    Figure 32. Global Favipiravir Tablets Average Price by Application (2019-2030) & (US$/Unit)
    Figure 33. North America Favipiravir Tablets Sales Quantity Market Share by Type (2019-2030)
    Figure 34. North America Favipiravir Tablets Sales Quantity Market Share by Application (2019-2030)
    Figure 35. North America Favipiravir Tablets Sales Quantity Market Share by Country (2019-2030)
    Figure 36. North America Favipiravir Tablets Consumption Value Market Share by Country (2019-2030)
    Figure 37. United States Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Canada Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Mexico Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Europe Favipiravir Tablets Sales Quantity Market Share by Type (2019-2030)
    Figure 41. Europe Favipiravir Tablets Sales Quantity Market Share by Application (2019-2030)
    Figure 42. Europe Favipiravir Tablets Sales Quantity Market Share by Country (2019-2030)
    Figure 43. Europe Favipiravir Tablets Consumption Value Market Share by Country (2019-2030)
    Figure 44. Germany Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. France Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. United Kingdom Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Russia Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Italy Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Asia-Pacific Favipiravir Tablets Sales Quantity Market Share by Type (2019-2030)
    Figure 50. Asia-Pacific Favipiravir Tablets Sales Quantity Market Share by Application (2019-2030)
    Figure 51. Asia-Pacific Favipiravir Tablets Sales Quantity Market Share by Region (2019-2030)
    Figure 52. Asia-Pacific Favipiravir Tablets Consumption Value Market Share by Region (2019-2030)
    Figure 53. China Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Japan Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Korea Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. India Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Southeast Asia Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Australia Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. South America Favipiravir Tablets Sales Quantity Market Share by Type (2019-2030)
    Figure 60. South America Favipiravir Tablets Sales Quantity Market Share by Application (2019-2030)
    Figure 61. South America Favipiravir Tablets Sales Quantity Market Share by Country (2019-2030)
    Figure 62. South America Favipiravir Tablets Consumption Value Market Share by Country (2019-2030)
    Figure 63. Brazil Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Argentina Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Middle East & Africa Favipiravir Tablets Sales Quantity Market Share by Type (2019-2030)
    Figure 66. Middle East & Africa Favipiravir Tablets Sales Quantity Market Share by Application (2019-2030)
    Figure 67. Middle East & Africa Favipiravir Tablets Sales Quantity Market Share by Region (2019-2030)
    Figure 68. Middle East & Africa Favipiravir Tablets Consumption Value Market Share by Region (2019-2030)
    Figure 69. Turkey Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Egypt Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Saudi Arabia Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. South Africa Favipiravir Tablets Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Favipiravir Tablets Market Drivers
    Figure 74. Favipiravir Tablets Market Restraints
    Figure 75. Favipiravir Tablets Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Favipiravir Tablets in 2023
    Figure 78. Manufacturing Process Analysis of Favipiravir Tablets
    Figure 79. Favipiravir Tablets Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Companies Mentioned

ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm